An increase indicates significant organizational restructuring or workforce reduction in international markets, which may lead to future cost savings but reflects current operational disruption. A decrease suggests a more stable international workforce or the conclusion of a major restructuring phase.
This metric represents the financial charges incurred by the company for employee termination benefits and restructuring...
Comparable to 'Restructuring Charges' or 'Severance Costs' reported by other multinational pharmaceutical companies, though often aggregated at the global level rather than by specific geographic segment.
lly_segment_outside_united_states_severance_costs1